Anacetrapib reduces progression of atherosclerosis, mainly...

European Heart Journal 2015 / 01 Vol. 36; Iss. 1

Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin

Kuhnast, S., van der Tuin, S. J. L., van der Hoorn, J. W. A., van Klinken, J. B., Simic, B., Pieterman, E., Havekes, L. M., Landmesser, U., Luscher, T. F., Willems van Dijk, K., Rensen, P. C. N., Juke
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
36
Language:
english
Journal:
European Heart Journal
DOI:
10.1093/eurheartj/ehu319
Date:
January, 2015
File:
PDF, 1.22 MB
english, 2015
Conversion to is in progress
Conversion to is failed